Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
Identifieur interne : 001870 ( Ncbi/Curation ); précédent : 001869; suivant : 001871Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
Auteurs : Sinthujan Jegaskanda [Australie] ; Kirsten Vandenberg ; Karen L. Laurie [Australie] ; Liyen Loh [Australie] ; Marit Kramski [Australie] ; Wendy R. Winnall [Australie] ; Katherine Kedzierska [Australie] ; Steven Rockman ; Stephen J. Kent [Australie]Source :
- The Journal of infectious diseases [ 1537-6613 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps antiviraux (immunologie), Anticorps antiviraux (sang), Cellules tueuses naturelles (immunologie), Cytotoxicité à médiation cellulaire dépendante des anticorps (immunologie), Femelle, Glycoprotéine hémagglutinine du virus influenza (immunologie), Grippe humaine (), Grippe humaine (immunologie), Humains, Immunoglobulines par voie veineuse (usage thérapeutique), Jeune adulte, Mâle, Réactions croisées (immunologie), Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H7N9 du virus de la grippe A (immunologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Tests d'hémagglutination.
- MESH :
- immunologie : Anticorps antiviraux, Cellules tueuses naturelles, Cytotoxicité à médiation cellulaire dépendante des anticorps, Glycoprotéine hémagglutinine du virus influenza, Grippe humaine, Réactions croisées, Sous-type H1N1 du virus de la grippe A, Sous-type H7N9 du virus de la grippe A.
- sang : Anticorps antiviraux.
- usage thérapeutique : Immunoglobulines par voie veineuse.
- Adulte, Adulte d'âge moyen, Femelle, Grippe humaine, Humains, Jeune adulte, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus, Tests d'hémagglutination.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antibodies, Viral (blood), Antibodies, Viral (immunology), Antibody-Dependent Cell Cytotoxicity (immunology), Cross Reactions (immunology), Female, Hemagglutination Tests, Hemagglutinin Glycoproteins, Influenza Virus (immunology), Humans, Immunoglobulins, Intravenous (therapeutic use), Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H7N9 Subtype (immunology), Influenza, Human (immunology), Influenza, Human (therapy), Killer Cells, Natural (immunology), Male, Middle Aged, Young Adult.
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus.
- immunology : Antibody-Dependent Cell Cytotoxicity, Cross Reactions, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H7N9 Subtype, Influenza, Human, Killer Cells, Natural.
- chemical , therapeutic use : Immunoglobulins, Intravenous.
- therapy : Influenza, Human.
- Adult, Aged, Aged, 80 and over, Female, Hemagglutination Tests, Humans, Male, Middle Aged, Young Adult.
Abstract
Intravenous immunoglobulin (IVIG) is a purified pool of human antibodies from thousands of donors that is used to prevent or treat primary immune deficiency, several infectious diseases, and autoimmune diseases. The antibodies that mediate antibody-dependent cellular cytotoxicity (ADCC) against heterologous influenza strains may be present in IVIG preparations.
DOI: 10.1093/infdis/jiu334
PubMed: 24916185
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000811
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000811
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000833
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001870
Links to Exploration step
pubmed:24916185Curation
No country items
Kirsten Vandenberg<affiliation><nlm:affiliation>BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.</title><author><name sortKey="Jegaskanda, Sinthujan" sort="Jegaskanda, Sinthujan" uniqKey="Jegaskanda S" first="Sinthujan" last="Jegaskanda">Sinthujan Jegaskanda</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name><affiliation><nlm:affiliation>BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Loh, Liyen" sort="Loh, Liyen" uniqKey="Loh L" first="Liyen" last="Loh">Liyen Loh</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Kramski, Marit" sort="Kramski, Marit" uniqKey="Kramski M" first="Marit" last="Kramski">Marit Kramski</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Winnall, Wendy R" sort="Winnall, Wendy R" uniqKey="Winnall W" first="Wendy R" last="Winnall">Wendy R. Winnall</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Kedzierska, Katherine" sort="Kedzierska, Katherine" uniqKey="Kedzierska K" first="Katherine" last="Kedzierska">Katherine Kedzierska</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation></author><author><name sortKey="Kent, Stephen J" sort="Kent, Stephen J" uniqKey="Kent S" first="Stephen J" last="Kent">Stephen J. Kent</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24916185</idno><idno type="pmid">24916185</idno><idno type="doi">10.1093/infdis/jiu334</idno><idno type="wicri:Area/PubMed/Corpus">000811</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000811</idno><idno type="wicri:Area/PubMed/Curation">000811</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000811</idno><idno type="wicri:Area/PubMed/Checkpoint">000833</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000833</idno><idno type="wicri:Area/Ncbi/Merge">001870</idno><idno type="wicri:Area/Ncbi/Curation">001870</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.</title><author><name sortKey="Jegaskanda, Sinthujan" sort="Jegaskanda, Sinthujan" uniqKey="Jegaskanda S" first="Sinthujan" last="Jegaskanda">Sinthujan Jegaskanda</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Vandenberg, Kirsten" sort="Vandenberg, Kirsten" uniqKey="Vandenberg K" first="Kirsten" last="Vandenberg">Kirsten Vandenberg</name><affiliation><nlm:affiliation>BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>WHO Collaborating Centre for Reference and Research on Influenza, VIDRL, North Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Loh, Liyen" sort="Loh, Liyen" uniqKey="Loh L" first="Liyen" last="Loh">Liyen Loh</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Kramski, Marit" sort="Kramski, Marit" uniqKey="Kramski M" first="Marit" last="Kramski">Marit Kramski</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Winnall, Wendy R" sort="Winnall, Wendy R" uniqKey="Winnall W" first="Wendy R" last="Winnall">Wendy R. Winnall</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Kedzierska, Katherine" sort="Kedzierska, Katherine" uniqKey="Kedzierska K" first="Katherine" last="Kedzierska">Katherine Kedzierska</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Rockman, Steven" sort="Rockman, Steven" uniqKey="Rockman S" first="Steven" last="Rockman">Steven Rockman</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne BioCSL Ltd, Parkville, Victoria.</nlm:affiliation><wicri:noCountry code="subField">Victoria</wicri:noCountry></affiliation></author><author><name sortKey="Kent, Stephen J" sort="Kent, Stephen J" uniqKey="Kent S" first="Stephen J" last="Kent">Stephen J. Kent</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity, University of Melbourne.</nlm:affiliation><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="eISSN">1537-6613</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Antibody-Dependent Cell Cytotoxicity (immunology)</term><term>Cross Reactions (immunology)</term><term>Female</term><term>Hemagglutination Tests</term><term>Hemagglutinin Glycoproteins, Influenza Virus (immunology)</term><term>Humans</term><term>Immunoglobulins, Intravenous (therapeutic use)</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza A Virus, H7N9 Subtype (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (therapy)</term><term>Killer Cells, Natural (immunology)</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps antiviraux (immunologie)</term><term>Anticorps antiviraux (sang)</term><term>Cellules tueuses naturelles (immunologie)</term><term>Cytotoxicité à médiation cellulaire dépendante des anticorps (immunologie)</term><term>Femelle</term><term>Glycoprotéine hémagglutinine du virus influenza (immunologie)</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Humains</term><term>Immunoglobulines par voie veineuse (usage thérapeutique)</term><term>Jeune adulte</term><term>Mâle</term><term>Réactions croisées (immunologie)</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sous-type H7N9 du virus de la grippe A (immunologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tests d'hémagglutination</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Hemagglutinin Glycoproteins, Influenza Virus</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Cellules tueuses naturelles</term><term>Cytotoxicité à médiation cellulaire dépendante des anticorps</term><term>Glycoprotéine hémagglutinine du virus influenza</term><term>Grippe humaine</term><term>Réactions croisées</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Sous-type H7N9 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antibody-Dependent Cell Cytotoxicity</term><term>Cross Reactions</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza A Virus, H7N9 Subtype</term><term>Influenza, Human</term><term>Killer Cells, Natural</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Immunoglobulins, Intravenous</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Immunoglobulines par voie veineuse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Hemagglutination Tests</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tests d'hémagglutination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Intravenous immunoglobulin (IVIG) is a purified pool of human antibodies from thousands of donors that is used to prevent or treat primary immune deficiency, several infectious diseases, and autoimmune diseases. The antibodies that mediate antibody-dependent cellular cytotoxicity (ADCC) against heterologous influenza strains may be present in IVIG preparations.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001870 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001870 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:24916185
|texte= Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:24916185" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |